Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
This study has been completed.
Study NCT00729846 Information provided by California Retina Consultants
First Received on August 5, 2008. Last Updated on December 1, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Age Related Macular Degeneration
Choroidal Neovascularization
Macular Edema
Additional conditions recognized in this trial
Edema
Macular Degeneration
Neovascularization, Pathologic
Wet Macular Degeneration
More general conditions related to this trial
Choroid Diseases
Eye Diseases
Metaplasia
Pathologic Processes
Retinal Degeneration
Retinal Diseases
Signs and Symptoms
Uveal Diseases
Additional drug interventions recognized in this trial
Bevacizumab
Verteporfin
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Antineoplastic Agents
Dermatologic Agents
Growth Inhibitors
Growth Substances
Pharmacologic Actions
Photosensitizing Agents
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
California Retina Consultants
Novartis
Back to top of Main Content
